McLean and Genomind Prospective Study

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

September 22, 2017

Primary Completion Date

July 12, 2019

Study Completion Date

July 31, 2020

Conditions
Major Depressive DisorderPTSD
Interventions
GENETIC

Phlebotomy - Folate

This will be a blood draw performed at Visit 1 for Folate (one 7mL tube)

GENETIC

Cheek Swab

Participants will undergo a cheek swab to then be analyzed using the Genecept Assay created by Genomind, Inc. This will occur once during Visit 1.

OTHER

Self-report surveys

At visit 1 and at visit 3 and 4, participants will be asked to complete self report diagnostic surveys and surveys related to the objective aims of the study.

Trial Locations (1)

02478

McLean Hospital, Belmont

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Genomind, LLC

INDUSTRY

lead

Mclean Hospital

OTHER

NCT03113890 - McLean and Genomind Prospective Study | Biotech Hunter | Biotech Hunter